X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (17) 17
index medicus (17) 17
male (12) 12
oncology (10) 10
aged (8) 8
female (8) 8
middle aged (8) 8
genetic aspects (7) 7
cell line, tumor (6) 6
expression (6) 6
hematology (6) 6
cancer (5) 5
genetics & heredity (5) 5
oncogene proteins, fusion - genetics (5) 5
animals (4) 4
chromosomes, human, pair 14 - genetics (4) 4
gene (4) 4
in situ hybridization, fluorescence (4) 4
lymphoma, b-cell, marginal zone - genetics (4) 4
lymphomas (4) 4
mice (4) 4
translocation, genetic (4) 4
abnormalities (3) 3
activation (3) 3
analysis (3) 3
chromosomes, human, pair 18 - genetics (3) 3
karyotyping (3) 3
leukemia (3) 3
molecular sequence data (3) 3
mutation (3) 3
neoplasm proteins - genetics (3) 3
prognosis (3) 3
research (3) 3
xenograft model antitumor assays (3) 3
aberrations (2) 2
abridged index medicus (2) 2
adult (2) 2
biomarkers, tumor - genetics (2) 2
cancer research (2) 2
caspases - genetics (2) 2
cell growth (2) 2
cell proliferation (2) 2
cell proliferation - drug effects (2) 2
chemotherapy (2) 2
chromosome aberrations (2) 2
chromosome deletion (2) 2
cohort studies (2) 2
cytogenetic analysis (2) 2
dna-binding proteins - genetics (2) 2
gene expression regulation, neoplastic (2) 2
gene frequency (2) 2
genes, p53 (2) 2
igh (2) 2
janus kinase 3 - genetics (2) 2
leukemia, myelogenous, chronic, bcr-abl positive - genetics (2) 2
leukemia, prolymphocytic, t-cell - genetics (2) 2
lymphoma, b-cell, marginal zone - pathology (2) 2
lymphoma, mantle-cell - genetics (2) 2
mantle cell lymphoma (2) 2
mucosa-associated lymphoid tissue lymphoma translocation 1 protein (2) 2
multiple myeloma - genetics (2) 2
multiple myeloma - pathology (2) 2
mutation - genetics (2) 2
non-hodgkin's lymphomas (2) 2
non-hodgkins-lymphoma (2) 2
oligonucleotide array sequence analysis (2) 2
recurrence (2) 2
repressor proteins - genetics (2) 2
resistance (2) 2
signal transduction (2) 2
t (2) 2
t cells (2) 2
trisomy (2) 2
tumors (2) 2
1852-1921 (1) 1
5p15 (1) 1
aberration (1) 1
acute disease (1) 1
adaptor proteins, signal transducing - genetics (1) 1
adaptor proteins, signal transducing - metabolism (1) 1
adenocarcinoma - drug therapy (1) 1
adenocarcinoma - genetics (1) 1
adenocarcinoma - metabolism (1) 1
adenocarcinoma - secondary (1) 1
adolescent (1) 1
adolescents (1) 1
aged, 80 and over (1) 1
alleles (1) 1
alpha-v-beta-3 (1) 1
alphabeta integrin (1) 1
amino acid sequence (1) 1
aneuploidy (1) 1
angiogenesis (1) 1
angiogenesis inhibitors - administration & dosage (1) 1
anti-interleukin-6 monoclonal-antibody (1) 1
antibodies (1) 1
antibodies, monoclonal - pharmacology (1) 1
antimitotic agents (1) 1
antineoplastic agents (1) 1
antineoplastic agents - metabolism (1) 1
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Genes, Chromosomes and Cancer, ISSN 1045-2257, 04/2014, Volume 53, Issue 4, pp. 309 - 316
T‐cell prolymphocytic leukemia (T‐PLL) is an aggressive post‐thymic T‐cell malignancy characterized by the recurrent inv(14)(q11q32)/t(14;14)(q11;q32) or... 
ACTIVATION | DOMAIN | GENE | ONCOLOGY | EXPRESSION | GENETICS & HEREDITY | Amino Acid Sequence | Humans | Janus Kinase 3 - genetics | Leukemia, Prolymphocytic, T-Cell - genetics | Molecular Sequence Data | Female | Male | Aged | Mutation | Chromosomes, Human, Pair 14 - genetics | Cohort Studies | T cells | Leukemia | Genetic aspects | Index Medicus
Journal Article
Leukemia Research, ISSN 0145-2126, 03/2013, Volume 37, Issue 3, pp. 280 - 286
Secondary chromosomal aberrations may contribute to the development of a malignant phenotype in mantle cell lymphoma. Chromosomal band 5p15.33 represents a new... 
Breakpoints
Journal Article
Proceedings of the National Academy of Sciences of the United States of America, ISSN 0027-8424, 11/2009, Volume 106, Issue 47, pp. 19946 - 19951
A key element for the development of suitable anti-cancer drugs is the identification of cancer-specific enzymatic activities that can be therapeutically... 
T lymphocytes | Cytokines | B lymphocytes | B cell lymphoma | Cell lines | Antibodies | Signatures | Gene expression | Viability | Cells | DLBCL | NF-kB | CARMA1 | MULTIDISCIPLINARY SCIENCES | T-CELL | CHEMOTHERAPY | C-FLIP | MALIGNANCIES | INHIBITORS | DIFFERENTIATION | NF-KAPPA-B | EXPRESSION | LYMPHOCYTES | Cell Proliferation | Oligonucleotide Array Sequence Analysis | Humans | Gene Expression Regulation, Neoplastic | NF-kappa B - metabolism | Neoplasm Proteins - antagonists & inhibitors | Gene Expression Profiling | Neoplasm Proteins - metabolism | CARD Signaling Adaptor Proteins - genetics | Antineoplastic Agents - metabolism | CARD Signaling Adaptor Proteins - metabolism | Caspases - metabolism | Neoplasm Proteins - genetics | Lung Neoplasms - enzymology | Caspases - genetics | Lymphoma, Large B-Cell, Diffuse - enzymology | Guanylate Cyclase - metabolism | Caspase Inhibitors | Animals | NF-kappa B - genetics | B-Cell CLL-Lymphoma 10 Protein | Adaptor Proteins, Signal Transducing - genetics | Cell Line, Tumor | Guanylate Cyclase - genetics | Signal Transduction - physiology | Mice | Mucosa-Associated Lymphoid Tissue Lymphoma Translocation 1 Protein | Adaptor Proteins, Signal Transducing - metabolism | Physiological aspects | Lymphomas | Genetic aspects | B cells | Properties | Proteases | Proteins | Cell growth | Pharmacology | Enzyme kinetics | Index Medicus | Biological Sciences
Journal Article
BMC Cancer, ISSN 1471-2407, 06/2010, Volume 10, Issue 1, pp. 295 - 295
Background: Pancreatic cancer is still associated with devastating prognosis. Real progress in treatment options has still not been achieved. Therefore new... 
EXTRACELLULAR-MATRIX PROTEINS | NUDE-MICE | OVEREXPRESSION | CANCER CELLS | ONCOLOGY | DUCTAL ADENOCARCINOMA | SCID MICE | RESISTANCE | CARCINOEMBRYONIC ANTIGEN | EXPRESSION | TUMORS | Immunohistochemistry | Lung Neoplasms - drug therapy | Pore Forming Cytotoxic Proteins - genetics | Cell Proliferation | Pancreatic Neoplasms - metabolism | Oligonucleotide Array Sequence Analysis | Humans | Middle Aged | Gene Expression Regulation, Neoplastic | Lung Neoplasms - pathology | Male | DNA-Binding Proteins - deficiency | Dose-Response Relationship, Drug | Pancreatic Neoplasms - drug therapy | Adenocarcinoma - metabolism | Lung Neoplasms - secondary | Time Factors | Cell Shape | Karyotyping | Female | Adenocarcinoma - genetics | Antineoplastic Agents - pharmacology | Cell Culture Techniques | Lung Neoplasms - genetics | Cell Separation | Mice, Inbred C57BL | Pancreatic Neoplasms - pathology | Gene Expression Profiling - methods | In Situ Hybridization, Fluorescence | Pancreatic Neoplasms - genetics | Pore Forming Cytotoxic Proteins - deficiency | Tumor Burden | DNA-Binding Proteins - genetics | Adenocarcinoma - drug therapy | Adenocarcinoma - secondary | Mice, Knockout | Xenograft Model Antitumor Assays | Animals | Cell Line, Tumor | Mice | Mutation | Gene amplification | Care and treatment | Prognosis | Lung cancer | Pancreatic cancer | Development and progression | Genetic aspects | Research | Risk factors | Index Medicus
Journal Article
Molecular Cancer, ISSN 1476-4598, 11/2013, Volume 12, Issue 1, pp. 144 - 144
Background: Tumors may develop resistance to specific angiogenic inhibitors via activation of alternative pathways. Therefore, multiple angiogenic pathways... 
Angiogenesis | Gliobastoma | Prolactin receptor | Endostatin | Tumstatin | GLIOMA-CELLS | BIOCHEMISTRY & MOLECULAR BIOLOGY | ALPHA(V)BETA INTEGRIN | BRAIN-TUMORS | BREAST-CANCER CELLS | ONCOLOGY | ALPHA-V-BETA-3 | IN-VIVO | RESISTANCE | EXPRESSION | Humans | Brain Neoplasms - pathology | Brain Neoplasms - blood supply | Integrins - metabolism | Brain Neoplasms - metabolism | Antineoplastic Combined Chemotherapy Protocols - pharmacology | Angiogenesis Inhibitors - administration & dosage | Human Umbilical Vein Endothelial Cells - physiology | Glioblastoma - metabolism | Cell Survival - drug effects | Human Umbilical Vein Endothelial Cells - drug effects | Signal Transduction | Autoantigens - administration & dosage | Brain Neoplasms - drug therapy | Mice, SCID | Receptors, Prolactin - metabolism | Xenograft Model Antitumor Assays | Collagen Type IV - administration & dosage | Animals | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Endostatins - administration & dosage | Glioblastoma - pathology | Cell Line, Tumor | Cell Proliferation - drug effects | Mice | Glioblastoma - drug therapy | Glioblastoma - blood supply | Sus scrofa | Integrins - antagonists & inhibitors | Apoptosis | Antimitotic agents | Growth | Prolactin | Analysis | Hostages | Antineoplastic agents | Glioblastoma multiforme | Biotechnology industry | Integrins | Endothelium | Cell growth | Brain research | Brain cancer | Software | Experiments | Cancer therapies | Binding sites | Tumors | Cancer | Index Medicus
Journal Article
Journal Article
The Journal of Clinical Endocrinology & Metabolism, ISSN 0021-972X, 06/2019, Volume 104, Issue 10, pp. 4630 - 4638
Molecular mechanisms causing the broad phenotypic diversity of external masculinization in individuals with 45,X/46,XY mosaicism are poorly understood.... 
Index Medicus | Abridged Index Medicus
Journal Article
Journal Article
International Journal of Surgical Pathology, ISSN 1066-8969, 07/2008, Volume 16, Issue 3, pp. 301 - 307
Journal Article